356 related articles for article (PubMed ID: 31203404)
21. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.
Dudeck O; Zeile M; Pink D; Pech M; Tunn PU; Reichardt P; Ludwig WD; Hamm B
J Magn Reson Imaging; 2008 May; 27(5):1109-13. PubMed ID: 18425832
[TBL] [Abstract][Full Text] [Related]
22. Pediatric skeletal diffusion-weighted magnetic resonance imaging, part 2: current and emerging applications.
Chaturvedi A
Pediatr Radiol; 2021 Aug; 51(9):1575-1588. PubMed ID: 34018037
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.
Low RN; Gurney J
J Magn Reson Imaging; 2007 Apr; 25(4):848-58. PubMed ID: 17335018
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcoma subtypes: Magnetic resonance and quantitative diffusion weighted imaging criteria.
Zeitoun R; Shokry AM; Ahmed Khaleel S; Mogahed SM
J Egypt Natl Canc Inst; 2018 Mar; 30(1):39-44. PubMed ID: 29429892
[TBL] [Abstract][Full Text] [Related]
26. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging.
Ahlawat S; Fayad LM
Eur J Radiol; 2018 May; 102():195-201. PubMed ID: 29685535
[TBL] [Abstract][Full Text] [Related]
27. Can diffusion weighting replace gadolinium enhancement in magnetic resonance enterography for inflammatory bowel disease in children?
Khachab F; Loundou A; Roman C; Colavolpe N; Aschero A; Bourlière-Najean B; Daidj N; Desvignes C; Pico H; Gorincour G; Auquier P; Petit P
Pediatr Radiol; 2018 Sep; 48(10):1432-1440. PubMed ID: 29982955
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
29. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
30. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
31. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
[TBL] [Abstract][Full Text] [Related]
32. Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression.
Li X; Hu Y; Xie Y; Lu R; Li Q; Tao H; Chen S
Eur Radiol; 2023 Jun; 33(6):3961-3973. PubMed ID: 36462043
[TBL] [Abstract][Full Text] [Related]
33. Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI.
Chun CW; Jung JY; Baik JS; Jee WH; Kim SK; Shin SH
J Magn Reson Imaging; 2018 Jan; 47(1):60-68. PubMed ID: 28432835
[TBL] [Abstract][Full Text] [Related]
34. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma.
Liu K; Peng W; Zhou Z
Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737
[TBL] [Abstract][Full Text] [Related]
35. Whole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?
Debs P; Fayad LM; Romo CG; Ahlawat S
Eur J Radiol; 2023 May; 162():110802. PubMed ID: 37001256
[TBL] [Abstract][Full Text] [Related]
36. Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
Caro-Domínguez P; Gupta AA; Chavhan GB
Pediatr Radiol; 2018 Jan; 48(1):85-93. PubMed ID: 28921384
[TBL] [Abstract][Full Text] [Related]
37. Effects of contrast-enhancement on diffusion weighted imaging and apparent diffusion coefficient measurements in 3-T magnetic resonance imaging of breast lesions.
Cipolla V; Guerrieri D; Bonito G; Celsa S; de Felice C
Acta Radiol; 2018 Aug; 59(8):902-908. PubMed ID: 29110505
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis.
Surov A; Nagata S; Razek AA; Tirumani SH; Wienke A; Kahn T
Skeletal Radiol; 2015 Jul; 44(7):995-1000. PubMed ID: 25916616
[TBL] [Abstract][Full Text] [Related]
39. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
40. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging of brain tumors: a short temporal interval assessment.
Li X; Qu JR; Luo JP; Li J; Zhang HK; Shao NN; Kwok K; Zhang SN; Li YL; Liu CC; Zee CS; Li HL
J Magn Reson Imaging; 2014 Sep; 40(3):616-21. PubMed ID: 24925118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
